Key result
Esophageal variceal sclerotherapy triggers delayed cardiac tamponade via inadvertent pericardial injection.
Why the study?
Cardiac tamponade and constrictive pericarditis are rare but serious complications following endoscopic sclerotherapy of esophageal varices that require clinical awareness.
Case Report (n=1)
Cardiac tamponade and constrictive pericarditis are rare but severe complications of endoscopic sclerotherapy that should be considered in patients presenting with inadequate cardiac output and pulsus paradoxus.
Clinicians should consider pericardial tamponade after esophageal sclerotherapy; single case leaves open incidence and prevention.
We report a case of suspected esophageal perforation with injection of a sclerosing agent into the pericardium during endoscopic sclerotherapy of esophageal varices. Immediately after the procedure, the patient developed fever and a pericardial friction rub. Eight months later, he presented with cardiac tamponade and constrictive pericarditis. This complication should be considered whenever a patient presents with inadequate cardiac output, venous congestion, and a pulsus paradoxus following sclerotherapy.
No takes yet. Share an insight, caveat, or question.
David L. Brown (1987) conducted a case report in Esophageal varices (n=1). Endoscopic sclerotherapy was evaluated on Cardiac tamponade and constrictive pericarditis. Endoscopic sclerotherapy of esophageal varices was complicated by suspected esophageal perforation and injection of a sclerosing agent into the pericardium, leading to cardiac tamponade 8 months later.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: